Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1474065

GTEX

7840661a-8d4f-508a-aa66-17d4569fd036

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • OXIDATIVE_PHOSPHORYLATION+0.318
  • HEDGEHOG_SIGNALING+0.228
  • KRAS_SIGNALING_DN+0.222
  • SPERMATOGENESIS+0.193
  • MYOGENESIS-0.009
  • UV_RESPONSE_DN-0.028
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.043
  • ESTROGEN_RESPONSE_EARLY-0.059
  • PANCREAS_BETA_CELLS-0.065
  • FATTY_ACID_METABOLISM-0.072

Top 10 suppressed

  • INTERFERON_ALPHA_RESPONSE-0.599
  • INTERFERON_GAMMA_RESPONSE-0.511
  • IL6_JAK_STAT3_SIGNALING-0.453
  • ANGIOGENESIS-0.441
  • INFLAMMATORY_RESPONSE-0.406
  • CHOLESTEROL_HOMEOSTASIS-0.404
  • G2M_CHECKPOINT-0.370
  • E2F_TARGETS-0.368
  • COAGULATION-0.351
  • APOPTOSIS-0.334

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1370619
brain-umap@2
GTEX0.976
2SRR1322555
brain-umap@2
GTEX0.975
3SRR1477634
brain-umap@2
GTEX0.974
4SRR1335651
brain-umap@2
GTEX0.973
5SRR1465356
brain-umap@2
GTEX0.971
6SRR1359388
brain-umap@2
GTEX0.971
7SRR1359192
brain-umap@2
GTEX0.964
8SRR1376597
brain-umap@2
GTEX0.961
9SRR600560
brain-umap@2
GTEX0.961
10SRR1367870
brain-umap@2
GTEX0.961

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 4 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
OXIDATIVE_PHOSPHORYLATION0.318Remibrutinib— uncovered
HEDGEHOG_SIGNALING0.228Inavolisib— uncovered
KRAS_SIGNALING_DN0.222Remibrutinib— uncovered
SPERMATOGENESIS0.193Inavolisib— uncovered